Guided Therapeutics, Inc.
GTHP
$0.1088
$0.00888.80%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.31% | 7.76% | -76.37% | -4.15% | 42.98% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 4.35% | 4.55% | 4.76% |
| Total Amortization of Deferred Charges | -4.55% | 22.22% | -43.75% | -3.03% | 3.13% |
| Total Other Non-Cash Items | -100.00% | 135.71% | 115.38% | 107.43% | -203.55% |
| Change in Net Operating Assets | 298.55% | -83.76% | 81.62% | 37.65% | 1,044.44% |
| Cash from Operations | 29.81% | -121.03% | -114.00% | 70.24% | 28.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 6.95% | -6.50% | -- | -- | -- |
| Total Debt Repaid | -151.81% | 40.29% | -202.17% | -2.22% | 70.78% |
| Issuance of Common Stock | 78.33% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 29.41% | -- | -- | -- |
| Cash from Financing | 34.18% | 790.91% | 195.65% | -123.47% | 227.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 339.51% | 52.35% | -16.44% | -4.29% | 77.67% |